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Anophthalmia and/ormicrophthalmia, pulmonary hypoplasia, diaphragmatic hernia, and cardiac defects are themain features of PDAC
syndrome. Recessive mutations in STRA6, encoding a membrane receptor for the retinol-binding protein, have been identified in
some cases with PDAC syndrome, although many cases have remained unexplained. Using whole-exome sequencing, we found that
two PDAC-syndrome-affected siblings, but not their unaffected sibling, were compound heterozygous for nonsense (c.355C>T
[p.Arg119*]) and frameshift (c.1201_1202insCT [p.Ile403Serfs*15]) mutations in retinoic acid receptor beta (RARB). Transfection studies
showed that p.Arg119* and p.Ile403Serfs*15 altered RARB had no transcriptional activity in response to ligands, confirming that the
mutations induced a loss of function. We then sequenced RARB in 15 subjects with anophthalmia and/or microphthalmia and at least
one other feature of PDAC syndrome. Surprisingly, three unrelated subjects with microphthalmia and diaphragmatic hernia showed de
novo missense mutations affecting the same codon; two of the subjects had the c.1159C>T (Arg387Cys) mutation, whereas the other
one carried the c.1159C>A (p.Arg387Ser) mutation. We found that compared to the wild-type receptor, p.Arg387Ser and p.Arg387Cys
altered RARB induced a 2- to 3-fold increase in transcriptional activity in response to retinoic acid ligands, suggesting a gain-of-function
mechanism. Our study thus suggests that both recessive and dominant mutations in RARB cause anophthalmia and/or microphthalmia
and diaphragmatic hernia, providing further evidence of the crucial role of the retinoic acid pathway during eye development and organ-
ogenesis.Anophthalmia or microphthalmia (A/M) refers to the
absence or reduced size of the axial diameter of the globe
in the ocular orbit, respectively. In over 50% of cases, A/
M is associated with other congenital abnormalities.1,2
The combination of pulmonary hypoplasia or agenesis,
diaphragmatic hernia or eventration, A/M, and cardiac de-
fects is characteristic of PDAC syndrome, which is also
known as Matthew-Wood syndrome or Spear syndrome
(MIM 601186).3 In some individuals, PDAC syndrome is
caused by autosomal-recessive mutations in STRA6
(MIM 610745), encoding a membrane receptor for the
retinol-binding protein.4,5 Many cases of PDAC syndrome,
however, remain unexplained.
In this study, we performed whole-exome sequencing in
a nonconsanguineous family affected by PDAC syndrome
to uncover the genetic cause (Figure 1A). The parents have
two healthy daughters and four affected children, of
whom two have all the features of PDAC syndrome and
two have at least two features of PDAC syndrome (individ-
uals II-1, II-4, II-5, and II-6 in family A, see Table 1 for clin-
ical details). This family was described previously (cases 1A1Centre Hospitalier Universitaire Sainte-Justine Research Center, Montreal, Q
Mount Sinai Hospital, Toronto, ON M5G 1X5, Canada; 3Division of Clinical a
1X8, Canada; 4Service de Ge´ne´tique Me´dicale, Hoˆpital Purpan, Centre Hospit
4555, Universite´ Toulouse III - Paul-Sabatier, 31000 Toulouse, France; 6Ge´ne´t
Nord, Assistance Publique – Hoˆpitaux de Paris, 93140 Bondy, France; 7Service
Ge´ne´tique Me´dicale, Hoˆtel Dieu, 63058 Clermont-Ferrand, France; 9School of
Genetics Unit, Birmingham Women’s Hospital, Birmingham B15 2TG, UK;
2B4, Canada
12These authors contributed equally to this work
*Correspondence: jacques.michaud@recherche-ste-justine.qc.ca
http://dx.doi.org/10.1016/j.ajhg.2013.08.014. 2013 by The American Societ
The Americ[II-4], 2A [II-5], and 3A [II-6] from family A in Chitayat
et al.3). STRA6was previously sequenced in one affected in-
dividual of this family, and no mutation was identified.
This study was approved by our institutional ethics com-
mittee, and informed consent was obtained from each
participant or legal guardian. Blood genomic DNA from
affected individuals II-4 and II-5 and the unaffected sister
(II-2) from family A was captured with the Agilent
SureSelect Human All Exon Capture V4 Kit and sequenced
(two paired-end 100 bp reads, three exomes per lane) with
Illumina HiSeq2000 at the McGill University Genome
Quebec Innovation Center (Montreal). Sequence process-
ing, alignment (with a Burrows-Wheeler algorithm), and
variant calling were done according to the Broad Institute
Genome Analysis Toolkit (GATK v.4) best practices, and
variant annotation was done with ANNOVAR.6 The
average exome coverage of the target bases was 111–
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Figure 1. Mutations in RARB in Individ-
uals with PDAC Syndrome
Sanger sequencing confirmed segregation
of the recessive mutations in RARB in fam-
ily A (A) and revealed that the mutations
were de novo in families B (B), C (C), and
D (D).position were retained. To identify potentially pathogenic
variants, we filtered out (1) synonymous variants or in-
tronic variants other than those affecting the consensus
splice sites, (2) variants seen in more than 2% of our in-
house exomes (n ¼ 1,000) from unrelated projects, and
(3) variants with a minor allele frequency greater than
0.5% in either the 1000 Genomes Project or the National
Heart, Lung, and Blood Institute (NHLBI) Exome
Sequencing Project Exome Variant Server (EVS). The
affected individuals did not share any rare coding or
splicing variants in STRA6 or ALDH1A3 (MIM 600463),
another gene involved in A/M and retinoic acid (RA)
signaling.7
Given that transmission of the phenotype in this family
was consistent with autosomal-recessive inheritance, we
searched the whole-exome data sets for genes harboring
homozygous or multiple rare variants in both affected
probands, but not in their unaffected sibling. There were
no such genes with rare homozygous variants. Only three
genes containing multiple rare variants in both affected
individuals were not shared by the unaffected sister:
PRPF39 (MIM 614907), RARB (MIM 180220), and GAPVD1
(MIM 611714). Sanger sequencing in the parents and the
siblings revealed that the variants in PRPF39 were in-
herited in cis, thus excluding this gene as a candidate.766 The American Journal of Human Genetics 93, 765–772, October 3, 2013The affected probands, but not the
unaffected sister, were compound
heterozygous and the parents were
singly heterozygous for the variants
in RARB and GAPVD1 (Figure 1A).
RARB (RefSeq accession number
NM_000965.3), which encodes RA
receptor beta (RARB), was found
to harbor two protein-truncating
mutations: nonsense c.355C>T
(p.Arg119*) and frameshift
c.1201_1202insCT (p.Ile403Serfs*
15). These variants are absent from
all public SNP databases (1000 Ge-
nomes, EVS, and dbSNP138) and
from our in-house exomes (n >
1,000). RARB has two major isoforms
noted in the UCSC Genome Browser
and three additional isoforms noted
in the Ensembl Genome Browser.
The major RefSeq isoform (RefSeq
NM_000965.3) has eight exons and
encodes a 448 aa protein. Both iden-tified mutations affect all known RARB isoforms
(Figure 2A).GAPVD1 (RefSeq NM_015635), which encodes
GTPase-activating protein and VPS9 domain 1, was found
to harbor two rare missense variants, c.2809C>T
(p.Arg937Trp) and c.3266G>T (p.Gly1089Val), in the pro-
bands. The p.Arg937Trp substitution is predicted to be
damaging by both SIFT (score 0.0) and PolyPhen-2 (score
1.0), but the p.Gly1089Val substitution is predicted to be
benign by both SIFT (score 0.2) and PolyPhen-2 (score
0.145). GAPVD1 is involved in endocytosis,8 phagosome
maturation,9 and regulation of the epidermal growth fac-
tor receptor10 but is not known to have a role in eye devel-
opment or embryogenesis. Because of the importance of
the RA pathway for eye and diaphragm development (dis-
cussed below), mutations in RARB were deemed more
likely to be pathogenic than those in GAPVD1.
RA receptors bind to DNA motifs known as RA response
elements (RAREs) to modulate transcription of target genes
by interacting with transcriptional corepressors and coacti-
vators. Upon binding to RA, the corepressor docking site
becomes hindered by helix 12 positioning, resulting in
the recruitment of coactivators and an increase in tran-
scription of target genes.11 The c.355C>T (p.Arg119*)
nonsense mutation is predicted to result in an inactive
truncated receptor lacking the second zinc finger of the
Table 1. Clinical Characteristics of Subjects with Mutations in RARB
Family A Family B Family C Family D
II-1 II-4 II-5 II-6 II-3 II-1 II-1
Ethnicity French Canadian and English French African (Angola [father]
and Congo [mother])
French
Consanguinity       
Mutation(s) NA c.355C>T (p.Arg119*)
and c.1201_1202insCT
(p.Ile403Serfs*15)
c.355C>T (p. Arg119*)
and c.1201_1202insCT
(p.Ile403Serfs*15)
NA c.1159 > A
(p.Arg387Ser)a
c.1159C>T (p.Arg387Cys)a c.1159C>T (p.Arg387Cys)a
Gender male female male male male male female
Age (age at death) (few hours; 34 weeks
of gestation)b
(few hours; 38 weeks
of gestation)
(21-week-old fetus)c (few hours;
term)
16 years (34-week-old fetus)c (few hours; 39 weeks
of gestation)
Bilateral A/M þ þ þ þ þ unilateral (left)
microphthalmia;
normal right eye
bilateral microphthalmia
Pulmonary hypoplasia NA þ þ NA  left lung with one hypoplastic
lobe; normal right lung
bilateral (predominant on
the left side)
Diaphragmatic hernia NA þ þ þ þ þ (left) þ (left)
Cardiac abnormality NA þ  NA   
Intellectual disability NA NA NA NA þ NA NA
Other  cleft palate, dysmorphisms,
small spleen, bicornate and
small uterus
dysmorphisms, unfixed
malrotated bowel
dysmorphisms  malrotated bowel, right
cryptorchydy, mild IUGR
(weight and length), and
OFC at the fifth percentile
bicornate uterus
Abbreviations are as follows: NA, not available; IUGR, intrauterine growth restriction; and OFC, occipitofrontal circumference.
aDe novo mutation.
bDied shortly after birth at 34 weeks as a result of a presumed tangled cord, although a diagnosis of PDAC was strongly suspected.
cTerminated pregnancy.
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Figure 2. Localization and Impact of the
Mutations in RARB
(A) Shown are the positions of the muta-
tions with respect to the different RARB
Ensembl-annotated transcripts that are
predicted to produce proteins. Numbering
on top is based on the cDNA positions of
Ensembl ENST00000330688 (identical to
RefSeq NM_000965.3).
(B) A schematic of RARB shows the DNA-
binding and hormone-binding domains.
Arrowheads above the protein show the
positions of the variants.
(C) The HomoloGene-generated amino
acid alignment of human RARB and its pre-
dicted orthologs shows the conservation of
the p.Arg387 residue.
(D) The three-dimensional structure of
RARB (Protein Data Bank ID 4DM8) in
the presence of the RA ligand (purple)
shows the proximity of the Arg387 residue
in helix 11 to the RA ligand.DNA-binding domain and the entire ligand-binding
domain (Figure 2B). Moreover, this mutation has the po-
tential to activate the nonsense-mediated mRNA decay
pathway, resulting in the degradation of the corresponding
transcript. The c.1201_1202insCT (p.Ile403Serfs*15) muta-
tion results in the substitution of a hydrophobic isoleucine
with serine, a polar residue, and the replacement of the last
52 amino acids with an aberrant extension of 15 amino
acids (Figure 2B). As part of helix 12, residue Ile403 is
thus predicted to play a key role in the recruitment of tran-
scriptional cofactors and response to ligand. As such,
in vitro studies have shown that Ile403 substitution with
serine in RARB confers an increased binding to corepressor
SMRT in the absence of ligand and thus results in reduced
transcriptional activity.12 Both mutations found in family
A are thus predicted to disrupt RARB function.
We tested the impact of these truncating mutations on
RARB activity by using a cellular one-hybrid luciferase-768 The American Journal of Human Genetics 93, 765–772, October 3, 2013reporter transcriptional assay as pre-
viously described.13 Expression plas-
mids encoding transcription factor
Gal4 DNA-binding domain fusions
to wild-type RARB or truncated vari-
ants p.Arg119* and p.Ile403Serfs*15
were generated and used for transfect-
ing human embryonic kidney 293
(HEK293) cells in the presence of a
luciferase reporter gene construct un-
der the control of a Gal4-binding
DNA upstream-activating sequence
(UAStkLuc). This assay allowed tran-
scriptional activity and response to
ligand to be directly compared be-
tween variants and the wild-type
receptor, avoiding any background
effect of endogenously expressedRARB in cells. Transfected HEK293 cells were treated
with the natural ligands all-trans RA (atRA) and its stereo-
isomer, 9-cis RA, which both act as pan-RAR agonists. As
expected, compared to that of wild-type RARB, the
transcriptional response of the p.Arg119* variant to the
two RA ligands was completely abolished, correlating
with its lack of ligand-binding domain (Figure 3). Similarly,
compared to wild-type RARB, the p.Ile403Serfs*15 variant
showed an impaired transcriptional response to retinoids.
In the p.Ile403Serfs*15 variant, the disruption of helix
12 and its replacement with an aberrant extension most
likely interfered with its ability to occlude the corepressor
docking site. All together, these results strongly suggest
that these truncating variants confer a loss of RARB func-
tion and explain the occurrence of PDAC syndrome in
family A.
We next sequenced all the coding exons and intron-
exon boundaries of RARB and the alternate exon 1
9-cis RA
Figure 3. Transcriptional Response of Human RARB Variants to
RA Ligands
HEK293 cells were seeded in 24-well plates and transfected with
100 ng per well of expression plasmid encoding either Gal4 fusion
of wild-type human RARB or p.Arg119*, p.Ile403Serfs*15,
p.Arg387Ser, or p.Arg387Cys RARB variants in the presence of
500 ng of UAStkLuc reporter-gene construct. All variant con-
structs, including p.Ile403Serfs*15 (carrying the additional out-
of-frame amino acid extension), were generated by site-directed
mutagenesis. Cells were treated with 1 mM atRA, 1 mM 9-cis RA,
or vehicle (DMSO; 1/1,000, v/v) for 16 hr. Luciferase values were
normalized to b-galactosidase activity and expressed as a fold
response compared to those of empty Gal4-transfected control
cells. Data were derived from three independent experiments per-
formed in triplicate. *p < 0.005 versus wild-type RARB response to
the respective RA ligand. Values represent means, and error bars
represent SEs.(Ensembl accession number ENST00000404969) in 15
additional individuals who had bilateral or unilateral A/
M and at least one additional feature of PDAC (diaphrag-
matic hernia, cardiac defect, or lung hypoplasia) and
who had been previously screened for mutations in
STRA6.14 In three unrelated subjects, who were all simplex
cases, we identified single heterozygous RARB missense
mutations affecting the same nucleotide. Of these, two
subjects (II-1 from family C and II-1 from family D)
harbored missense mutation c.1159C>T (p.Arg387Cys)
and one individual (II-3 from family B) harbored missense
mutation c.1159C>A (p.Arg387Ser) (Figures 1B and 1C).
These mutations were absent from the genomic DNA of
the parents, indicating that they occurred de novo. Using
six informative unlinked microsatellite markers
(D3S1754, D4S3351, D8S1179, D15S659, D14S587, and
D19S215), we confirmed the paternity and maternity in
these families, as previously described.15 Both c.1159C>T
(p.Arg387Cys) and c.1159C>A (p.Arg387Ser) are absent
from public SNP databases (EVS, 1000 Genomes, and
dbSNP138) and from our entire collection of in-house
exomes (n >1,000). They are both predicted to be
damaging by SIFT (score 0.0) and PolyPhen-2 (score 1.0)
and affect a highly conserved amino acid in helix 11 of
the ligand-binding domain (Figure 2C). Subject II-1 from
family C was a fetus for whom pregnancy was terminated
because of unilateral microphthalmia and left diaphrag-
matic hernia on prenatal ultrasound (Table 1). AutopsyThe Americalso showed hypoplasia of a pulmonary lobe on the left
side. Subject II-1 from family D was a newborn who passed
away within a few hours after birth because of a left dia-
phragmatic hernia. This subject also showed bilateral mi-
crophthalmia and pulmonary hypoplasia. Subject II-3
from family B is currently a 14-year-old male with bilateral
microphthalmia, corrected diaphragmatic hernia, and
abnormal cognitive development with spasticity (for clin-
ical details, see case 6 in Chitayat et al.3). We also
sequenced RARB in 11 cases with isolated bilateral A/M,
but we did not find any mutation in this gene.
The fact that the de novo mutations involved the same
residue (Arg387) suggests that they confer a specific prop-
erty to the protein. These mutations could induce a domi-
nant-negative effect or act through a gain-of-function
mechanism. In order to distinguish between these possibil-
ities, we sought to study the impact of these mutations by
using our one-hybrid functional assay. The p.Arg387Ser
and p.Arg387Cys altered RARB exhibited a significant
increase in their transcriptional response to atRA; they
reached 23- and 28-fold induction, respectively, compared
to 9-fold induction for wild-type RARB (Figure 3). Similar
activation levels were also obtained with the 9-cis RA
ligand. These results suggest that the two variants at
Arg387 provide increased transcriptional potential to
respond to retinoid ligands through a gain-of-function
mechanism. Explaining such an increase in activity will
require a more detailed mechanistic analysis.
We have identified compound-heterozygous truncating
mutations and de novo mutations affecting the same
RARB nucleotide in individuals with PDAC syndrome.
The occurrence of such mutations in individuals with a
similar and rare phenotype strongly suggests that they
cause PDAC syndrome. Indeed, several observations indi-
cate that the RA pathway plays a major role in the develop-
ment of the eyes, diaphragm, and lungs. RA is a metabolite
of retinol, a derivative of vitamin A. The importance of the
RA pathway in embryogenesis has been recognized for
decades, given that rats deficient in vitamin A give birth
to progeny with multiple congenital malformations,
including ocular abnormalities and diaphragmatic her-
nia.16 Circulating retinol is bound to retinol-binding
protein 4 (RBP4). The transmembrane protein STRA6
(stimulated by RA) facilitates the intracellular uptake of
the retinol-RBP complex.4 Mutations in STRA6 have been
identified in at least 24 individuals with A/M.5,14,17–19
Most of these subjects showed other features of PDAC
syndrome, but some of them had isolated A/M. Once
transported into the cell, retinol is successively oxidized
to retinaldehyde and RA. Mutations in ALDH1A3, which
encodes a retinaldehyde dehydrogenase that is responsible
for the oxidation of retinaldehyde into RA, have been
found to be responsible for A/M with variable neurodeve-
lopmental and cardiac features.7
In target cells, RA acts as a ligand for nuclear RA re-
ceptors. Several observations in mice suggest that these
receptors play a major role in eye, diaphragm, and lungan Journal of Human Genetics 93, 765–772, October 3, 2013 769
development. Mice lacking all Rarb isoforms displaymicro-
phthalmia.20,21 RA is generated in the epithelial ocular
compartment and diffuses in the neural-crest-cell-derived
periocular mesenchyme to activate RARB and RARG. In
turn, these receptors regulate the remodeling of the perioc-
ular mesenchyme, the growth of the ventral retina, and
the expression of Foxc1 and Pitx2, which play central roles
in the development of the anterior eye segment.22 Studies
of mutant mice lacking both Rara and Rarb subtypes have
also demonstrated the presence of diaphragmatic hernias
in a subset of offspring.23 Moreover, administration of
nitrofen to pregnant rodents is thought to cause diaphrag-
matic hernias, in part through downregulation of RA
receptor signaling (reviewed in Greer et al.24). Recent
studies have indicated that Rarb functions along a pathway
that directs development of the central tendon of the dia-
phragm.25 Finally, Rarb/ mice have smaller and more
numerous alveoli in their lungs.26 Rarb has been shown
to have a critical role in lung morphogenesis by inducing
Fgf10 expression in bud fields.27 Overall, these studies sup-
port our conclusion that loss of RARB function causes
PDAC syndrome in family A.
Our transfection experiments suggest that the de novo
mutations affecting Arg387 result in enhanced activity of
RARB in response to RA ligands, suggesting a gain-of-func-
tion mechanism. Whether these two substitutions induce
a conformational change that enhances protein stability,
favors coactivator recruitment, and/or increases RA bind-
ing affinity remains to be determined. Consistent with
this latter possibility, crystallographic studies have estab-
lished that the Arg387 residue is facing inward relative to
the ligand-binding pocket, in close proximity to the reti-
noid ligand (Figure 2D). Our model of gain-of-function
mutations thus suggests that an increase in RARB response
to retinoids might represent a primary cause of PDAC syn-
drome. Indeed, excess of vitamin A or RA during develop-
ment in mice causes various malformations, including
microphthalmia and diaphragmatic hernia.28–32 More-
over, expression of a constitutively active RAR transgene
in the developing eye results in animals that exhibit micro-
phthalmia.33 Similarly, zebrafish embryos exposed to 9-cis-
RA develop multiple developmental abnormalities,
including microphthalmia.34 RA is also teratogenic in hu-
mans.35 Interestingly, microphthalmia and diaphragmatic
hernia have been reported in some babies from women
exposed to RA during pregnancy.35,36
All together, our findings and the previous work
described above therefore suggest that both decreased
and increased RARB activity can result in PDAC syndrome.
A recent study showed that RA exposure during embryonic
development in mice was followed by decreased levels of
Raldh transcripts encoding RA-synthesizing enzymes and
increased levels of Cyp26a1 and Cyp26b1, mRNAs encod-
ing enzymes that catabolize RA.32 Overall, these changes
resulted in a decrease in RA levels. Restoration of RA levels
by maternal supplementation with low doses of RA after
the teratogenic insult rescued several developmental de-770 The American Journal of Human Genetics 93, 765–772, Octoberfects. Paradoxically, increased RARB signaling could thus
result in a secondary state of RA deficiency, which could
have an impact on this pathway at specific stages of devel-
opment. Alternatively, it is possible that some develop-
mental processes require a tight regulation of RARB targets,
given that too little or too much signaling has the same
consequence on these pathways.
In summary, we found that both recessive and dominant
RARB mutations affect RARB function in the context of
PDAC syndrome, opening a new window on the structural
and mechanistic basis of RA receptor activity as it relates to
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